Literature DB >> 11337934

Arg389Gly beta 1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo.

H G Xie1, V Dishy, G Sofowora, R B Kim, R Landau, R M Smiley, H H Zhou, A J Wood, P Harris, C M Stein.   

Abstract

There are marked interethnic differences in beta 1-adrenoceptor-mediated responsiveness, with sensitivity decreased in African-Americans and increased in Chinese compared with Caucasians. Therefore, the frequency of a common naturally occurring polymorphism of the human beta 1-adrenoceptor gene (Arg389Gly), which has functional importance in vitro, was determined in 194 African-Americans, 316 Caucasian-Americans, 221 Hispanic-Americans and 142 Chinese. African-Americans were found to have a significantly lower frequency of the Arg389 allele than the other three ethnic groups (all P < 0.01). In the populations studied, the order of the distribution of the Arg389 allele was: Chinese (74%) > Caucasians (72%) > Hispanics (67%) > African-Americans (58%). To determine the functional significance of the Arg389Gly beta 1-adrenoceptor polymorphism, in-vivo heart rate responses to exercise were compared in healthy subjects homozygous for the Arg (n = 9) and Gly (n = 8) alleles. Heart rate response to exercise was not affected by genotype (P = 0.4). Although ethnic differences in the frequency of the beta 1-adrenoceptor Arg389Gly polymorphism exist, the polymorphism does not appear to have functional significance in healthy subjects and therefore may not contribute to ethnic differences in response to drugs acting through the beta 1-adrenoceptor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11337934     DOI: 10.1097/00008571-200104000-00002

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  17 in total

Review 1.  Beta-adrenoceptor polymorphisms.

Authors:  K Leineweber; R Büscher; H Bruck; O-E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-28       Impact factor: 3.000

Review 2.  Receptor gene polymorphisms: lessons on functional relevance from the beta 1-adrenoceptor.

Authors:  Martin C Michel; Paul A Insel
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

3.  RAAS and adrenergic genes in heart failure: Function, predisposition and survival implications.

Authors:  Alberto J Alves; Nir Eynon; José Oliveira; Ehud Goldhammer
Journal:  World J Cardiol       Date:  2010-07-26

Review 4.  Race, common genetic variation, and therapeutic response disparities in heart failure.

Authors:  Mathew R Taylor; Albert Y Sun; Gordon Davis; Mona Fiuzat; Stephen B Liggett; Michael R Bristow
Journal:  JACC Heart Fail       Date:  2014-10-22       Impact factor: 12.035

Review 5.  The functional significance of genetic variation within the beta-adrenoceptor.

Authors:  A J Sandilands; K M O'Shaughnessy
Journal:  Br J Clin Pharmacol       Date:  2005-09       Impact factor: 4.335

6.  The Arg16Gly-β(2)-adrenoceptor single nucleotide polymorphism: exercise capacity and survival in patients with end-stage heart failure.

Authors:  Kirsten Leineweber; Ulrich H Frey; Gero Tenderich; Mohammad Reza Toliat; Armin Zittermann; Peter Nürnberg; Reiner Körfer; Winfried Siffert; Gerd Heusch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-08-29       Impact factor: 3.000

7.  β1-adrenoceptor gene Arg389Gly polymorphism and essential hypertension risk in general population: a meta-analysis.

Authors:  Hao Wang; Jielin Liu; Kuo Liu; Ya Liu; Zuoguang Wang; Yuqing Lou; Qiuli Niu; Wei Gu; Lijuan Wang; Mei Li; Xiaoling Zhu; Shaojun Wen
Journal:  Mol Biol Rep       Date:  2013-04-16       Impact factor: 2.316

8.  Beta1-adrenergic receptor gene polymorphisms and response to beta1-adrenergic receptor blockade in patients with essential hypertension.

Authors:  J Karlsson; L Lind; P Hallberg; K Michaëlsson; L Kurland; T Kahan; K Malmqvist; K P Ohman; F Nyström; H Melhus
Journal:  Clin Cardiol       Date:  2004-06       Impact factor: 2.882

9.  Greater inotropic and cyclic AMP responses evoked by noradrenaline through Arg389 beta 1-adrenoceptors versus Gly389 beta 1-adrenoceptors in isolated human atrial myocardium.

Authors:  A J Sandilands; K M O'Shaughnessy; M J Brown
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

Review 10.  Beta-adrenergic receptor polymorphisms: cardiovascular disease associations and pharmacogenetics.

Authors:  Julie A Johnson; Steven G Terra
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.